Full Paper
performed. The energy values quoted include the zero point
energy contribution.
tate formed almost immediately after the addition of iBuLi which
1
was filtered and collected (yield 0.66 g, 4.62 mmol, 92%). H NMR
(400.1 MHz, [D8]THF, 300 K): d=6.54 (1H, d, 3JH–H =5.39 Hz, H6),
3
3
5.71 (1H, t, JH–H =5.59 Hz, H4), 4.25 (1H, t, JH–H =5.49 Hz, H5), 3.97
Synthesis of 2-tBu(C5H5N)Li·PMDETA (1t·PMDETA)
3
3
(1H, t, JH–H =5.59 Hz, H3), 3.63 (1H, quin, JH–H =4.51 Hz, H2), 1.84
(2H, m, JH–H =5.30 Hz, a-CH2), 1.29 (1H, brs, CH), 0.83 ppm (6H, d,
3
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and
dissolved in hexane (5 mL) by gently warming with a heat gun for
a few seconds. PMDETA (0.21 mL, 1 mmol) was added via syringe
producing a thick oil. THF was slowly added dropwise with stirring
until a homogeneous yellow solution was obtained. Yellow crystals
formed after standing the solution at À308C for one week (yield
0.211 g, 67%). 1H NMR (400.1 MHz, C6D12, 300 K): d=6.56 (1H, d,
3JH–H =6.57 Hz, CH3); 13C NMR (100.6 MHz, [D8]THF, 300 K): d=150.0
(C6), 126.5 (C4), 95.1 (C3), 89.2 (C5), 53.3 (C2), 43.9 (a-CH2), 23.8
(CH3), 22.8 ppm (CH); 7Li NMR (155.5 MHz, [D8]THF, 300 K): d=
0.29 ppm.
3
3
3JH–H =4.70 Hz, H6), 5.85 (1H, t, JH–H =5.82 Hz, H4), 4.07 (1H, t, JH–
H =5.29 Hz, H5), 3.95 (1H, brs, H3), 3.54 (1H, brd, 3JH–H =4.56 Hz,
H2), 2.46 (4H, brs, 2CH2 PMDETA), 2.38 (7H, brs, CH3 +2CH2
PMDETA), 2.32 (12H, s, 4Me PMDETA), 0.87 ppm (9H, s, CH3);
13C NMR (100.6 MHz, C6D12, 300 K): d=150.8 (C6), 128.8 (C4), 95.2
(C3), 87.4 (C5), 69.5 (C2), 58.1 (CH3 PMDETA), 55.0 (CH2 PMDETA),
46.0 (4Me PMDETA), 45.2 (CH2 PMDETA), 41.1 (tBu quaternary),
25.7 ppm (CH3); 7Li NMR (155.5 MHz, C6D12, 300 K): d=0.82 ppm;
elemental analysis (%) for C18H37N4Li: calcd: C 68.31, H 11.78, N
17.70; found: C 67.64, H 11.85, N 17.33.
Synthesis of 2-sBu(C5H5N)Li (1s)
Pyridine (1.12 mL, 14 mmol) was added to a Schlenk flask contain-
ing hexane (10 mL). sBuLi (10 mL, 1.4m in hexane, 14 mmol) was
added via syringe, giving a yellow solution. A pale yellow precipi-
tate formed upon cooling the solution to À308C which was fil-
tered and collected (yield 0.88 g, 6.16 mmol, 44%). 1H NMR
3
(400.1 MHz, C6D12, 300 K): d=6.73 (1H, d, JH–H =5.25 Hz, H6), 6.04
3
(1H, m, H4), 5.08 (1H, brt, JH–H =5.25 Hz, H5), 4.40 (1H, brm, H3),
3.10 (1H, brm, H2), 1.55 (2H, m, a-CH+1 from CH2), 0.97 (1H, m,
1 from CH2), 0.85 (3H, m, CH3), 0.77 ppm (3H, m, CH3); 13C NMR
(100.6 MHz, C6D12, 300 K): d=147.7 (C6), 125.7 (C4), 96.6 (C5), 95.1
(C3), 60.6 (C2), 37.2 (CH), 24.8 (CH2), 15.0 (CH3), 11.4 ppm (CH3);
7Li NMR (155.5 MHz, C6D12, 300 K): d=À1.97 ppm.
Synthesis of 2-tBu(C5H5N)Li·Me4AEE (1t·Me4AEE)
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and
dissolved in hexane (5 mL) by gently warming with a heat gun for
a few seconds. Me4AEE (0.19 mL, 1 mmol) was added via syringe
producing a thick oil. THF was slowly added dropwise with stirring
until a homogeneous yellow solution was obtained. Yellow crystals
formed after standing the solution at À308C for one week (yield
0.097 g, 32%). 1H NMR (400.1 MHz, C6D12, 300 K): d=6.62 (1H, d,
Synthesis of 1,4-dihydropyridylLi·Me6TREN (2)
Pyridine (0.32 mL, 4 mmol) and Me6TREN (0.52 mL, 2 mmol) were
added to a Schlenk flask containing hexane (5 mL). nBuLi (1.25 mL,
1.6m in hexane, 2 mmol) was added via syringe, giving an orange
solution. This solution was heated at 508C for one hour then al-
lowed to slowly cool, depositing an orange-red oil which con-
tained a small crop of crystalline material. The oil and solvent mix-
ture was decanted off and the sticky crystals dried and collected
3
3JH–H =5.60 Hz, H6), 5.92 (1H, dq, JH–H =5.60, 1.23 Hz, H4), 4.36 (1H,
3
3
dt, JH–H =5.60, 1.34 Hz, H5), 4.18 (1H, dd, JH–H =4.89 Hz, H3), 3.55
(4H, t, 3JH–H =5.52 Hz, O-CH2 Me4AEE), 3.46 (1H, d, 3JH–H =5.00 Hz,
3
H2), 2.50 (4H, t, JH–H =5.55 Hz, CH2-N Me4AEE), 2.24 (s, 12H, N-CH3
Me4AEE), 0.84 ppm (s, 9H, CH3); 13C NMR (100.6 MHz, C6D12, 300 K):
d=151.0 (C6), 128.2 (C4), 97.2 (C3), 91.6 (C5), 69.4 (O-CH2 Me4AEE),
66.9 (C2), 59.4 (CH2-N Me4AEE), 45.8 (N-CH3 Me4AEE), 40.9 (tBu qua-
ternary), 25.7 ppm (CH3); 7Li NMR (155.5 MHz, C6D12, 300 K): d=
0.34 ppm; elemental analysis (%) for C17H34N3LiO: calcd: C 67.29, H
11.29, N 13.85; found: C 66.67, H 11.22, N 14.10.
1
(yield 0.121 g, 19%). H NMR (400.1 MHz, C6D6, 300 K): d=6.50 (2H,
d, 3JH–H =7.27 Hz, H2), 4.56 (2H, m, H3), 4.38 (2H, brt, H4), 2.01–
1.91 ppm (brs with shoulder, 30H, Me6TREN); 13C NMR (100.6 MHz,
C6D6, 300 K): d=143.5 (C2), 89.4 (C3), 57.5 (CH2 Me6TREN), 51.9
(CH2 Me6TREN), 45.6 (Me Me6TREN), 27.9 ppm (C4); 7Li NMR
(155.5 MHz, C6D6, 300 K): d=0.68 ppm.
Synthesis of 2-tBu(C5H5N)Li·TMEDA (1t·TMEDA)
2-i-Butylpyridine
A sample of 1t (143 mg, 1 mmol) was added to a Schlenk flask and
dissolved in hexane (5 mL) by gently warming with a heat gun for
a few seconds. TMEDA (0.15 mL, 1 mmol) was added via syringe
giving a homogeneous yellow solution. Orange crystals formed
1H NMR (400.1 MHz, CDCl3, 300 K): d=8.53 (1H, brs, H6), 7.59 (1H,
t, 3JH–H =7.64 Hz, H4), 7.11 (2H, brt, H3+H5), 2.66 (2H, d, JH–H
7.30 Hz, a-CH2), 2.11 (1H, m, JH–H =6.87 Hz, b-CH), 0.93 ppm (6H,
d, 3JH–H =6.61 Hz, CH3); 13C NMR (400.1 MHz, CDCl3, 300 K): d=
161.6 (C2), 149.1 (C6), 136.3 (C4), 123.7 (C3), 121.0 (C5), 47.6 (CH2),
29.3 (CH), 22.5 ppm (CH3).
3
=
3
after standing the solution at À308C for one week (yield 0.212 g,
3
82%). 1H NMR (400.1 MHz, C6D12, 300 K): d=6.70 (1H, d, JH–H
=
=
=
3
5.19 Hz, H6), 6.04 (1H, t, 3JH–H =5.54 Hz, H4), 4.58 (1H, t, JH–H
3
5.19 Hz, H5), 4.07 (1H, m, 3JH–H =5.19 Hz, H3), 3.30 (1H, d, JH–H
4.67 Hz, H2), 2.34 (4H, s, CH2 TMEDA), 2.26 (12H, s, Me TMEDA),
0.82 ppm (9H, s, CH3); 13C NMR (100.6 MHz, C6D12, 300 K): d=151.3
(C6), 127.0 (C4), 94.4 (C3), 93.8 (C5), 66.2 (C2), 58.9 (CH2 TMEDA),
46.8 (Me TMEDA), 41.6 (tBu quaternary), 26.0 ppm (CH3); 7Li NMR
(155.5 MHz, C6D12, 300 K): d=À1.67 ppm.
2-s-Butylpyridine
1H NMR (400.1 MHz, CDCl3, 300 K): d=8.56 (1H, d, 3JH–H =5.05 Hz,
H6), 7.65 (1H, t, 3JH–H =7.46 Hz, H4), 7.15 (2H, m, H3+H5), 2.87
(1H, m, 3JH–H =6.80 Hz, a-CH), 1.78 (1H, m, 3JH–H =7.46 Hz, CH2),
1.65 (1H, m, 3JH–H =7.02 Hz, CH2), 1.29 (3H, d, 3JH–H =7.02 Hz,
CHCH3), 0.87 ppm (3H, t, 3JH–H =7.46 Hz, CH2CH3); 13C NMR
(400.1 MHz, CDCl3, 300 K): d=165.7 (C2), 147.9 (C6), 136.4 (C4),
121.3 (C3), 121.7 (C5), 42.8 (CH), 29.4 (CH2), 19.8 (CHCH3), 11.5 ppm
(CH2CH3).
Synthesis of 2-iBu(C5H5N)Li (1i)
Pyridine (0.40 mL, 5 mmol) was added to a Schlenk flask containing
hexane (10 mL). iBuLi (3.12 mL, 1.6m in hexane, 5 mmol) was
added via syringe, giving a yellow solution. A pale yellow precipi-
Chem. Eur. J. 2015, 21, 14410 – 14420
14418
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim